The Defence Acquisition Council (DAC) has recently approved procurement proposals worth Rs 79,000 crore across three services and it has cleared AoN (Acceptance of Necessity) of Rs 3.3 trillion in financial year 2026 (FY26).
'The additional Rafales will be from a vastly improved version compared to the 36 acquired for the IAF under the 2016 deal.'
For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.
The Defence Acquisition Council (DAC) has approved procurement of long range rockets, missiles, radar systems and military platforms worth Rs 79,000 crore to bolster the military's combat prowess.
The largest tranche came in July, in the wake of Operation Sindoor, with the DAC according acceptance of necessity -- or initial approval -- for 10 capital acquisition proposals amounting to approximately 1.05 trillion through indigenous sourcing.
'The tools of warfare are changing. The MoD must deepen its engagement with technology thinkers that can present compelling visions of where warfare may be heading.'
'India is clearly moving toward more targeted treatment pathways in high-burden cancers.'
There is a decisive shift in how cancer may soon be confronted and, hopefully, defeated.
...compared with 153,000 in all of 2024.
Goldman Sachs is bullish about Indian aerospace and defence, preferring private companies over public sector units (PSUs) as the country ramps up its export target for the sector to Rs 50,000 crore by FY29 from Rs 23,600 crore last year. The American investment bank's top 'buy' recommendations include Solar Industries, Bharat Electronics, Data Patterns and PTC Industries, while Bharat Dynamics is rated 'sell'.
HAL executives said deliveries of the Tejas Mk1A to the IAF would begin within this year, but only after the successful completion of the weapons-firing trials currently underway.
'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.'
Pharma giant AstraZeneca's Covid-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British newspaper The Telegraph.
United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is unknown, according to court papers being quoted in the UK media.
The private consortium would invest more than Rs 1,200 crore over the next five years to launch a constellation of 12 state-of-the-art Earth Observation satellites equipped with panchromatic, multispectral, hyperspectral, and microwave SAR (synthetic aperture radar) sensors.
Despite these rare occurrences, the pharmaceutical company maintains that extensive clinical trial data and real-world evidence consistently support the vaccine's safety and efficacy.
Karnataka Chief Minister Siddaramaiah alleged that the rushed approval and distribution of the COVID-19 vaccine may be a contributing factor to cardiac arrest deaths, citing several international studies that recently suggested a possible link between the vaccines and a rise in heart attacks.
Pixxel has raised $95 million in funding and with the company's commercial Firefly satellites up in orbit selling data globally 'we know and seen what it takes to make this business work.'
On Wednesday, August 23, 2023, Tejas, the Light Combat Aircraft LSP-7, successfully fired the ASTRA indigenous Beyond Visual Range (BVR) air-to-air missile off the coast of Goa.
India has not accepted the demand of the UK for inclusion of a 'data exclusivity' provision in the free trade agreement, announced on May 6, in a bid to protect the interests of the domestic generic drugs industry, an official said. During the negotiations, the UK had asked to include this provision in the trade pact.
Initially, we will look to take a small batch of a few hundred students, with a plan to increase this to 5,000 students in the next five years, and eventually 10,000 by 2036.'
After Chennai, it is Coimbatore, Madurai, and Tiruchirappalli, that are emerging as manufacturing hubs. Coimbatore is India's top Tier-II city in terms of the number of GCCs, according to a report by Cushman & Wakefield.
AstraZeneca has stressed that patient safety is its "highest priority" and pointed out that regulators around the world "consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects".
'There's something called deterrence by punishment.' 'That means you hit in a manner calculated to raise costs and consequences for Pakistan, so that the next time it attempts a Pahalgam-like attack, it has to think ten times.'
Defence stocks have been on a tear, with the Nifty India Defence index hitting all-time highs. Over the past week, the index jumped around 7 per cent, far outpacing the flat performance of the Nifty 50. Over the past month, its 12 per cent gain has trebled the benchmark's return.
Enhertu currently costs around Rs 1.6 lakh per 100-milligram injection.
News reports that GE Aerospace has delivered the first of 99 F404-IN20 engines ordered by Hindustan Aeronautics (HAL) for the Tejas Mk-1A has revived interest in the HAL stock.
'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'
The researchers analysed 2580,021 test results from nose and throat swabs taken from 384,543 participants aged 18 years or older between December 1, 2020 and May 16, 2021.
The study also noted that the booster dosage of the company's COVID-19 vaccine Vaxzevria also increased the immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.
We have applied for marketing authorisation to the EMA through AstraZeneca. We will not sell the vaccine in the EU, said a company source.
Researchers at Public Health Scotland and the University of Edinburgh, UK, found that the Pfizer-BioNTech vaccine offered better protection against the Delta variant compared to the Oxford-AstraZeneca preventive, known as Covishield in India.
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.
Backing the 12-16 weeks gap between the two doses of Covishield in the country, the chief investigator of the AstraZeneca vaccine clinical trials on Friday said that the level of protection provided by one dose of the preventive significantly increases in the second and third months after the jab.
The Commonwealth of Dominica will bestow its highest national award, the Dominica Award of Honour, upon Prime Minister Narendra Modi this month in recognition of his contributions to Dominica during the COVID-19 pandemic and his dedication to strengthening the partnership between the two countries.
AstraZeneca and the University of Oxford, as the trial sponsor, said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.
The phase 3 trial is being implemented as part of Operation Warp Speed, a multi-agency collaboration led by the US Health and Human Services, which aims at accelerating the development and manufacturing of medical countermeasures for COVID-19 and delivering 300 million doses of an effective vaccine by January 2021.
The British-Swedish pharmaceutical major and the UK's medicines regulator said that the vaccines produced by Oxford University in collaboration with AstraZeneca to protect against COVID-19 are safe.
The UK's National Health Service was already lining up thousands of medics and volunteers to be ready to deliver jabs up and down the country.
Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances